MedPath

Effect of Sweetness Intensity of a Sucrose Solution on Blood Glucose Regulation and Energy Intake

Early Phase 1
Completed
Conditions
Blood Glucose, Low
Hunger
Interventions
Drug: Lactisole
Other: Sucrose
Registration Number
NCT04991714
Lead Sponsor
University of Vienna
Brief Summary

The aim of the present study is to investigate the influence of the modulation of the sweetness intensity of a carbohydrate (sucrose)-containing solution on metabolic effects, in particular the regulation of blood glucose concentration and regulation of hunger \& satiety.

Detailed Description

The study is designed as a randomised cross-over intervention study with four interventions. The study investigates the influence of sweetness modulation by Rebaudioside M (sweetness enhancement) and Lactisol (sweetness inhibition) of a 10% sucrose solution, corresponding to the concentration of a regular soft drink, on blood glucose regulation (blood glucose concentration and regulating hormones) in healthy male volunteers. Furthermore, the study assesses ad libitum energy intake, individual feelings of hunger and satiety, metabolic responses to the interventions, and preference for sweet-tasting foods such as sugar and sweeteners. In addition, the participants' individual thresholds for sweet taste, as well as morphological markers for taste sensitivity and body composition will be recorded as potential influencing factors.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • male
  • healthy
  • non-smoking
  • normal taste responses towards sweet taste
Exclusion Criteria
  • female
  • regular smokers
  • disturbed glucose and/or lipid metabolism
  • regular intake of medication
  • known allergies against one of the test compounds
  • ageusia
  • alcohol or drug addiction
  • intake of antibiotics within the past 2 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sucrose + Reb M + LactisoleRebaudioside M10% sucrose + 60 mg/L Rebaudioside M + 30 mg/ L Lactisole
Sucrose + Reb M + LactisoleSucrose10% sucrose + 60 mg/L Rebaudioside M + 30 mg/ L Lactisole
Sucrose + Reb MSucrose10% sucrose + 60 mg/L Rebaudioside M
Sucrose + Reb M + LactisoleLactisole10% sucrose + 60 mg/L Rebaudioside M + 30 mg/ L Lactisole
SucroseSucrose10% solution in water
Sucrose + LactisoleLactisole10% sucrose + 30 mg/ L Lactisole
Sucrose + LactisoleSucrose10% sucrose + 30 mg/ L Lactisole
Sucrose + Reb MRebaudioside M10% sucrose + 60 mg/L Rebaudioside M
Primary Outcome Measures
NameTimeMethod
Blood glucose concentrationover a time span of 120 minutes after drinking the test solution

Glucose concentration \[mg/dL\] in plasma samples before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution

GLP-1 concentrationover a time span of 120 minutes after drinking the test solution

Glucagon-like peptide 1 concentration in plasma samples \[mmol/L\] before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution

GIP-concentrationover a time span of 120 minutes after drinking the test solution

Gastric inhibitory polypeptide concentration in plasma samples \[mmol/L\] before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution

Insulin concentrationover a time span of 120 minutes after drinking the test solution

Insulin concentration \[mmol/L\] in plasma samples before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution

Secondary Outcome Measures
NameTimeMethod
Metabolic changesover a time span of 120 minutes after drinking the test solution

Metabolome analysis in plasma samples \[mmol/L\] before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution

Food intake120 minutes after drinking of the test solution

Ad libitum Food intake from a standardized breakfast

Trial Locations

Locations (1)

Christian Doppler Laboratory for Taste Research

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath